Pivotal role of oxidative stress in tumor metastasis under diabetic conditions in mice

Journal of Controlled Release

Volumn 170, Issue 2, 2013, Pages 191-197

  Ikemura, Mai ^a   Nishikawa, Makiya ^a   Kusamori, Kosuke ^a   Fukuoka, Miho ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Diabetes; Hyperglycemia; Reactive oxygen species; Tumor metastasis

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; GLUCOSE; MEDICAL PROBLEMS; PATHOLOGY; TUMORS;

BLOOD GLUCOSE LEVEL; DIABETIC PATIENT; FIREFLY LUCIFERASE; HYPERGLYCEMIA; LONG CIRCULATING; LUCIFERASE ASSAYS; REACTIVE OXYGEN SPECIES; TUMOR METASTASIS;

MAMMALS;

GLUCOSE; HYDROGEN PEROXIDE; LIPID PEROXIDE; LUCIFERASE; MACROGOL; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; CATALASE; CATALASE-POLYETHYLENE GLYCOL; GLUCOSE BLOOD LEVEL; MACROGOL DERIVATIVE; MALONALDEHYDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COUNT; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIVER; LUNG; MALE; MELANOMA B16; MELANOMA METASTASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TUMOR CELL; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; DIABETES MELLITUS, EXPERIMENTAL; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; METABOLISM; PATHOLOGY; SECONDARY;

ANIMALS; BLOOD GLUCOSE; CATALASE; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; HYDROGEN PEROXIDE; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MALE; MALONDIALDEHYDE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS;

EID: 84879475989     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.05.028     Document Type: Article

References (27)

1. Z. Fatehi-Hassanabad, C.B. Chan, B.L. Furman, Reactive oxygen species and endo-thelial function in diabetes, Eur. J. Pharmacol. 636 (2010) 8-17.
2. S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care 27 (2004) 1047-1053. (Pubitemid 38579764)
3. P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, R. Vigneri, Diabetes and cancer. Endocr. Relat, Cancer 16 (2009) 1103-1123.
4. M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, M. Noda, S. Tsugane, Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan, Arch. Intern. Med. 166 (2006) 1871-1877. (Pubitemid 44455170)
5. B.B. Barone, H.C. Yeh, C.F. Snyder, K.S. Peairs, K.B. Stein, R.L. Derr, A.C. Wolff, F.L. Brancati, Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis, J. Am. Med. Assoc. 300 (2008) 2754-2764.
6. A.C. Maritim, R.A. Sanders, J.B. 3rd Watkins, Diabetes, oxidative stress, and antioxidants: a review, J. Biochem. Mol. Toxicol. 17 (2003) 24-38. (Pubitemid 36410972)
7. J.L. Evans, I.D. Goldfine, B.A. Maddux, G.M. Grodsky, Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr. Rev. 23 (2002) 599-622. (Pubitemid 35191625)
8. A.M. Vincent, J.W. Russell, P. Low, E.L. Feldman, Oxidative stress in the pathogenesis of diabetic neuropathy, Endocr. Rev. 25 (2004) 612-628. (Pubitemid 39096072)
9. G. Pani, T. Galeotti, P. Chiarugi, Metastasis: cancer cell's escape from oxidative stress, Cancer Metastasis Rev. 29 (2010) 351-378.
10. M. Ikemura, M. Nishikawa, K. Hyoudou, Y. Kobayashi, F. Yamashita, M. Hashida, Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice, Mol. Pharm. 7 (2010) 2069-2076.
11. M. Nishikawa, M. Hashida, Y. Takakura, Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis, Adv. Drug Deliv. Rev. 61 (2009) 319-326.
12. Y. Yabe, M. Nishikawa, A. Tamada, Y. Takakura, M. Hashida, Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives, J. Pharmacol. Exp. Ther. 289 (1999) 1176-1184. (Pubitemid 29191281)
13. K. Hyoudou, M. Nishikawa, Y. Umeyama, Y. Kobayashi, F. Yamashita, M. Hashida, Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells, Clin. Cancer Res. 10 (2004) 7685-7691. (Pubitemid 39557533)
14. Y. Kimura, M. Sumiyoshi, High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice, Nutr. Cancer 59 (2007) 207-216. (Pubitemid 350230739)
15. M.N. VanSaun, I.K. Lee, M.K. Washington, L. Matrisian, D.L. Gorden, High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorec-tal metastases and promotes primary dysplasia in a murine model, Am. J. Pathol. 175 (2009) 355-364.
16. S. Lenzen, The mechanisms of alloxan- and streptozotocin-induced diabetes, Diabetologia 51 (2008) 216-226.
17. R.P. Robertson, Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes, J. Biol. Chem. 279 (2004) 42351-42354.
18. M.S. Al Shamsi, A. Amin, E. Adeghate, Beneficial effect of vitamin E on the metabolic parameters of diabetic rats, Mol. Cell. Biochem. 261 (2004) 35-42. (Pubitemid 39004514)
19. P. Hasanein, S. Shahidi, Effects of combined treatment with vitamins C and E on passive avoidance learning and memory in diabetic rats, Neurobiol. Learn. Mem. 93 (2010) 472-478.
20. F. Okada, M. Kobayashi, H. Tanaka, T. Kobayashi, H. Tazawa, Y. Iuchi, K. Onuma, M. Hosokawa, M.C. Dinauer, N.H. Hunt, The role of nicotinamide adenine dinucleo-tide phosphate oxidase-derived reactive oxygen species in the acquisition of met-astatic ability of tumor cells, Am. J. Pathol. 169 (2006) 294-302.
21. K. Hyoudou, M. Nishikawa, Y. Kobayashi, Y. Kuramoto, F. Yamashita, M. Hashida, Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase, Clin. Exp. Metastasis 23 (2006) 269-278.
22. Y. Takahashi, M. Nishikawa, N. Kobayashi, Y. Takakura, Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases, J. Control. Release 105 (2005) 332-343. (Pubitemid 40941997)
23. K. Hyoudou, M. Nishikawa, Y. Kobayashi, Y. Umeyama, F. Yamashita, M. Hashida, PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal, Free Radic. Biol. Med. 41 (2006) 1449-1458. (Pubitemid 44466729)
24. Y. Zheng, M. Nishikawa, M. Ikemura, F. Yamashita, M. Hashida, Development of bone-targeted catalase derivatives for inhibition of bone metastasis of tumor cells in mice, J. Pharm. Sci. 101 (2012) 552-557.
25. Y. Yabe, N. Kobayashi, T. Nishihashi, R. Takahashi, M. Nishikawa, Y. Takakura, M. Hashida, Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives, J. Pharmacol. Exp. Ther. 298 (2001) 894-899. (Pubitemid 32761901)
26. Y. Hirano, E. Sakurai, A. Matsubara, Y. Ogura, Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo, Invest. Ophthalmol. Vis. Sci. 51 (2010) 508-515.
27. S.L. Bowker, S.R. Majumdar, P. Veugelers, J.A. Johnson, Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin, Diabetes Care 29 (2006) 254-258. (Pubitemid 44106500)